| 1017 | HSAP00P0000265302 | -1.668 | 8.313 | -3.318 | 0.004418 | 0.06096 | -2.226 | CDK2 | cyclin-dependent kinase 2 | ENSG00000123374 | 116953 | 1017 | NM_001798 |
| 1019 | HSAP00P0000266822 | -2.426 | 10.53 | -8.347 | 3.504e-07 | 0.0001766 | 6.915 | CDK4 | cyclin-dependent kinase 4 | ENSG00000135446 | 123829, 609048 | 1019 | NM_000075 |
| 1021 | HSAP00P0000166047 | 0.7444 | 5.664 | 1.802 | 0.09067 | 0.3344 | -5.014 | CDK6 | cyclin-dependent kinase 6 | ENSG00000105810 | 603368, 612223 | 1021 | BC027989 |
| 1026 | HSAP00P0000141889 | -1.791 | 9.354 | -3.511 | 0.002944 | 0.04742 | -1.836 | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | ENSG00000124762 | 116899 | 1026 | L47232 |
| 1029 | HSAP00P0000193465 | -1.499 | 8.209 | -4.572 | 0.0003235 | 0.01162 | 0.3093 | CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | ENSG00000147889 | 151623, 155601, 155755, 600160, 606719 | 1029 | BC015960 |
| 10912 | HSAP00P0000198803 | -1.365 | 7.569 | -3.575 | 0.002577 | 0.04374 | -1.707 | GADD45G | growth arrest and DNA-damage-inducible, gamma | ENSG00000130222 | 604949 | 10912 | NM_006705 |
| 1111 | HSAP00P0000253117 | -1.574 | 6.979 | -2.689 | 0.01627 | 0.133 | -3.461 | CHEK1 | CHK1 checkpoint homolog (S. pombe) | ENSG00000149554 | 603078 | 1111 | NM_001274 |
| 11200 | HSAP00P0000413903 | -0.5522 | 9.449 | -1.784 | 0.09368 | 0.3398 | -5.042 | CHEK2 | CHK2 checkpoint homolog (S. pombe) | ENSG00000183765 | 114480, 176807, 259500, 604373, 609265 | 11200 | NM_001005735 |
| 143686 | HSAP00P0000247950 | 0.7903 | 6.574 | 2.971 | 0.009103 | 0.09448 | -2.915 | SESN3 | sestrin 3 | ENSG00000149212 | 607768 | 143686 | NM_144665 |
| 1643 | HSAP00P0000236286 | -1.442 | 8.731 | -4.64 | 0.0002816 | 0.01066 | 0.4448 | DDB2 | damage-specific DNA binding protein 2, 48kDa | ENSG00000134574 | 278740, 600811 | 1643 | NM_000107 |
| 1647 | HSAP00P0000017223 | 0.7236 | 9.025 | 2.043 | 0.05808 | 0.2662 | -4.624 | GADD45A | growth arrest and DNA-damage-inducible, alpha | ENSG00000116717 | 126335 | 1647 | NM_001924 |
| 25898 | HSAP00P0000104855 | -2.191 | 6.249 | -4.937 | 0.0001542 | 0.007287 | 1.033 | RCHY1 | ring finger and CHY zinc finger domain containing 1 | ENSG00000163743 | 607680 | 25898 | BC015464 |
| 27113 | HSAP00P0000386101 | 1.352 | 8.207 | 4.956 | 0.0001486 | 0.007101 | 1.069 | BBC3 | BCL2 binding component 3 | ENSG00000105327 | 605854 | 27113 | AF354655 |
| 27244 | HSAP00P0000149133 | -1.79 | 9.195 | -5.15 | 0.0001008 | 0.005576 | 1.448 | SESN1 | sestrin 1 | ENSG00000080546 | 606103 | 27244 | NM_014454 |
| 2810 | HSAP00P0000008463 | 1.375 | 5.359 | 4.013 | 0.001028 | 0.02444 | -0.8173 | SFN | stratifin | ENSG00000175793 | 601290 | 2810 | BC023552 |
| 317 | HSAP00P0000270033 | 2.433 | 4.28 | 2.023 | 0.06031 | 0.2716 | -4.658 | APAF1 | apoptotic peptidase activating factor 1 | ENSG00000120868 | 602233 | 317 | NM_181861 |
| 3479 | HSAP00P0000270797 | 2.762 | 4.26 | 3.86 | 0.001416 | 0.03006 | -1.128 | IGF1 | insulin-like growth factor 1 (somatomedin C) | ENSG00000017427 | 147440, 608747 | 3479 | NM_000618 |
| 3486 | HSAP00P0000161846 | 1.222 | 6.805 | 3.102 | 0.00694 | 0.08028 | -2.657 | IGFBP3 | insulin-like growth factor binding protein 3 | ENSG00000146674 | 146732 | 3486 | AK127537 |
| 355 | HSAP00P0000219940 | 0.8801 | 4.005 | 2.329 | 0.03348 | 0.1992 | -4.128 | FAS | Fas (TNF receptor superfamily, member 6) | ENSG00000026103 | 134637, 601859 | 355 | NM_000043 |
| 3732 | HSAP00P0000235586 | 0.6102 | 7.527 | 2.804 | 0.01286 | 0.116 | -3.241 | CD82 | CD82 molecule | ENSG00000085117 | 176807, 600623 | 3732 | NM_002231 |
| 4193 | HSAP00P0000267929 | -1.21 | 4.533 | -3.735 | 0.001842 | 0.03551 | -1.383 | MDM2 | Mdm2 p53 binding protein homolog (mouse) | ENSG00000135679 | 164785 | 4193 | AF201370 |
| 4194 | HSAP00P0000037987 | -0.8941 | 5.335 | -2.372 | 0.03075 | 0.1902 | -4.051 | MDM4 | Mdm4 p53 binding protein homolog (mouse) | ENSG00000198625 | 602704 | 4194 | BX640923 |
| 4616 | HSAP00P0000367095 | 1.986 | 7.552 | 7.371 | 1.709e-06 | 0.0004519 | 5.406 | GADD45B | growth arrest and DNA-damage-inducible, beta | ENSG00000099860 | 604948 | 4616 | AL050044 |
| 472 | HSAP00P0000249027 | 0.5376 | 3.84 | 2.072 | 0.05505 | 0.2591 | -4.577 | ATM | ataxia telangiectasia mutated | ENSG00000149311 | 114480, 208900, 607585 | 472 | AF035328 |
| 50484 | HSAP00P0000186211 | -1.367 | 7.005 | -3.798 | 0.001614 | 0.03275 | -1.255 | RRM2B | ribonucleotide reductase M2 B (TP53 inducible) | ENSG00000048392 | 604712, 612075, 613077 | 50484 | AB036063 |
| 5054 | HSAP00P0000168598 | 1.307 | 8.574 | 3.386 | 0.003826 | 0.05588 | -2.088 | SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | ENSG00000106366 | 173360, 613329 | 5054 | NM_000602 |
| 51246 | HSAP00P0000079999 | -3.175 | 8.542 | -10.93 | 9.058e-09 | 2.032e-05 | 10.29 | SHISA5 | shisa homolog 5 (Xenopus laevis) | ENSG00000164054 | 607290 | 51246 | AK056328 |
| 51512 | HSAP00P0000419548 | 0.8837 | 7.391 | 3.425 | 0.003528 | 0.05312 | -2.01 | GTSE1 | G-2 and S-phase expressed 1 | ENSG00000075218 | 607477 | 51512 | NM_016426 |
| 5268 | HSAP00P0000363792 | 1.173 | 8.52 | 4.638 | 0.000283 | 0.01069 | 0.44 | SERPINB5 | serpin peptidase inhibitor, clade B (ovalbumin), member 5 | ENSG00000206075 | 154790 | 5268 | BX640597 |
| 5366 | HSAP00P0000363465 | -1.4 | 7.232 | -2.804 | 0.01286 | 0.1159 | -3.24 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | ENSG00000141682 | 604959 | 5366 | NM_021127 |
| 54205 | HSAP00P0000158902 | 0.9881 | 4.51 | 2.808 | 0.01275 | 0.1155 | -3.233 | CYCS | cytochrome c, somatic | ENSG00000172115 | 123970, 612004 | 54205 | NM_018947 |
| 545 | HSAP00P0000091555 | -1.56 | 7.214 | -3.407 | 0.003665 | 0.05439 | -2.046 | ATR | ataxia telangiectasia and Rad3 related | ENSG00000175054 | 210600, 601215 | 545 | NM_001184 |
| 55240 | HSAP00P0000059033 | 1.224 | 6.557 | 3.865 | 0.001403 | 0.0299 | -1.119 | STEAP3 | STEAP family member 3 | ENSG00000115107 | 609671 | 55240 | NM_018234 |
| 55367 | HSAP00P0000228507 | -1.192 | 7.475 | -5.312 | 7.338e-05 | 0.00456 | 1.758 | PIDD | p53-induced death domain protein | ENSG00000177595 | 605247 | 55367 | NM_145886 |
| 56475 | HSAP00P0000061714 | 0.9411 | 4.195 | 4.129 | 0.0008076 | 0.0209 | -0.5825 | RPRM | reprimo, TP53 dependent G2 arrest mediator candidate | ENSG00000177519 | 612171 | 56475 | NM_019845 |
| 5728 | HSAP00P0000219804 | -0.7229 | 5.468 | -1.88 | 0.07871 | 0.3113 | -4.892 | PTEN | phosphatase and tensin homolog | ENSG00000171862 | 137800, 153480, 155600, 158350, 174900, 176807, 176920, 188470, 275355, 276950, 601728, 605309, 607174, 608089, 612242, 613028 | 5728 | NM_000314 |
| 575 | HSAP00P0000188950 | 0.9149 | 6.517 | 3.896 | 0.001314 | 0.02865 | -1.055 | BAI1 | brain-specific angiogenesis inhibitor 1 | ENSG00000181790 | 602682 | 575 | NM_001702 |
| 581 | HSAP00P0000387186 | -0.6788 | 8.209 | -2.369 | 0.03093 | 0.1908 | -4.056 | BAX | BCL2-associated X protein | ENSG00000087088 | 600040 | 581 | NM_138764 |
| 595 | HSAP00P0000244217 | -5.498 | 10.03 | -16.28 | 2.749e-11 | 1.629e-06 | 15.18 | CCND1 | cyclin D1 | ENSG00000110092 | 114500, 151400, 168461, 193300, 254500 | 595 | NM_053056 |
| 6241 | HSAP00P0000045776 | -3.733 | 8.688 | -10.71 | 1.198e-08 | 2.402e-05 | 10.04 | RRM2 | ribonucleotide reductase M2 | ENSG00000171848 | 180390 | 6241 | BC028932 |
| 637 | HSAP00P0000410508 | -2.077 | 6.011 | -4.333 | 0.0005284 | 0.01584 | -0.1694 | BID | BH3 interacting domain death agonist | ENSG00000015475 | 601997 | 637 | NM_001196 |
| 63970 | HSAP00P0000253596 | 0.8512 | 4.692 | 2.901 | 0.01054 | 0.103 | -3.053 | TP53AIP1 | tumor protein p53 regulated apoptosis inducing protein 1 | ENSG00000120471 | 605426 | 63970 | NM_022112 |
| 64065 | HSAP00P0000151904 | -2.905 | 9.502 | -7.648 | 1.077e-06 | 0.0003488 | 5.848 | PERP | PERP, TP53 apoptosis effector | ENSG00000112378 | 609301 | 64065 | NM_022121 |
| 64326 | HSAP00P0000034350 | -2.334 | 7.045 | -4.751 | 0.0002247 | 0.009265 | 0.6651 | RFWD2 | ring finger and WD repeat domain 2 | ENSG00000143207 | 608067 | 64326 | NM_022457 |
| 64393 | HSAP00P0000094556 | -1.363 | 6.777 | -1.933 | 0.07133 | 0.296 | -4.806 | ZMAT3 | zinc finger, matrin-type 3 | ENSG00000172667 | 606452 | 64393 | NM_022470 |
| 6477 | HSAP00P0000324414 | -1.458 | 8.328 | -4.84 | 0.0001878 | 0.00823 | 0.8404 | SIAH1 | seven in absentia homolog 1 (Drosophila) | ENSG00000196470 | 602212 | 6477 | NM_003031 |
| 7057 | HSAP00P0000301347 | 1.122 | 4.149 | 1.751 | 0.09936 | 0.3502 | -5.093 | THBS1 | thrombospondin 1 | ENSG00000137801 | 188060 | 7057 | NM_003246 |
| 7157 | HSAP00P0000336667 | -3.681 | 7.909 | -10.61 | 1.371e-08 | 2.571e-05 | 9.918 | TP53 | tumor protein p53 | ENSG00000141510 | 114480, 114500, 114550, 151623, 161550, 191170, 202300, 259500, 260350, 260500, 607107 | 7157 | NM_000546 |
| 7161 | HSAP00P0000001947 | 0.9811 | 7.233 | 3.619 | 0.002348 | 0.04129 | -1.617 | TP73 | tumor protein p73 | ENSG00000078900 | 601990 | 7161 | AY040827 |
| 7249 | HSAP00P0000315423 | -0.8952 | 10.69 | -3.535 | 0.002801 | 0.04599 | -1.788 | TSC2 | tuberous sclerosis 2 | ENSG00000103197 | 191092, 191100, 606690 | 7249 | NM_000548 |
| 836 | HSAP00P0000113353 | 1.135 | 4.075 | 3.674 | 0.002091 | 0.03842 | -1.505 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | ENSG00000164305 | 600636 | 836 | NM_004346 |
| 83667 | HSAP00P0000009148 | -1.058 | 6.635 | -3.497 | 0.003033 | 0.04833 | -1.864 | SESN2 | sestrin 2 | ENSG00000130766 | 607767 | 83667 | NM_031459 |
| 842 | HSAP00P0000004673 | 0.781 | 8.572 | 2.951 | 0.009504 | 0.09691 | -2.956 | CASP9 | caspase 9, apoptosis-related cysteine peptidase | ENSG00000132906 | 602234 | 842 | NM_001229 |
| 8493 | HSAP00P0000351349 | 0.6431 | 4.266 | 2.471 | 0.02529 | 0.1707 | -3.871 | PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | ENSG00000170836 | 114480, 605100 | 8493 | NM_003620 |
| 85417 | HSAP00P0000425481 | 1.223 | 4.271 | 4.196 | 0.0007024 | 0.01907 | -0.4467 | CCNB3 | cyclin B3 | ENSG00000147082 | 300456 | 85417 | NM_033031 |
| 8795 | HSAP00P0000179389 | 0.693 | 9.937 | 2.163 | 0.0462 | 0.2366 | -4.42 | TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | ENSG00000120889 | 275355, 603612 | 8795 | NM_003842 |
| 891 | HSAP00P0000119174 | -2.579 | 8.771 | -6.626 | 6.233e-06 | 0.0009844 | 4.158 | CCNB1 | cyclin B1 | ENSG00000134057 | 123836 | 891 | AY027764 |
| 894 | HSAP00P0000255150 | 2.069 | 6.701 | 4.505 | 0.000371 | 0.0127 | 0.1757 | CCND2 | cyclin D2 | ENSG00000118971 | 123833 | 894 | NM_001759 |
| 896 | HSAP00P0000143095 | 0.5851 | 9.927 | 2.465 | 0.02557 | 0.1717 | -3.881 | CCND3 | cyclin D3 | ENSG00000112576 | 123834 | 896 | NM_001760 |
| 898 | HSAP00P0000378070 | -0.6166 | 7.428 | -2.27 | 0.0376 | 0.212 | -4.234 | CCNE1 | cyclin E1 | ENSG00000105173 | 123837 | 898 | NM_001238 |
| 901 | HSAP00P0000105340 | -1.106 | 6.579 | -2.554 | 0.0214 | 0.1553 | -3.717 | CCNG2 | cyclin G2 | ENSG00000138764 | 603203 | 901 | BC032518 |
| 9133 | HSAP00P0000305740 | -2.27 | 7.372 | -6.321 | 1.081e-05 | 0.001358 | 3.624 | CCNB2 | cyclin B2 | ENSG00000157456 | 602755 | 9133 | NM_004701 |
| 9134 | HSAP00P0000185442 | -0.6125 | 8.064 | -2.23 | 0.04065 | 0.2213 | -4.305 | CCNE2 | cyclin E2 | ENSG00000175305 | 603775 | 9134 | BC007015 |
| 9538 | HSAP00P0000253072 | -2.519 | 8.993 | -8.74 | 1.915e-07 | 0.0001219 | 7.485 | EI24 | etoposide induced 2.4 mRNA | ENSG00000149547 | 605170 | 9538 | NM_004879 |
| 9540 | HSAP00P0000046817 | 0.8224 | 7.601 | 3.44 | 0.003421 | 0.05211 | -1.98 | TP53I3 | tumor protein p53 inducible protein 3 | ENSG00000115129 | 605171 | 9540 | NM_004881 |
| 983 | HSAP00P0000216274 | -2.996 | 9.62 | -8.487 | 2.82e-07 | 0.0001538 | 7.12 | CDK1 | cyclin-dependent kinase 1 | ENSG00000170312 | 116940 | 983 | NM_001786 |